Charles F. Wagner Jr., EVP & Chief Financial Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 3,744 shares at $295.43 ($1.1M) on 2023-03-17, disclosed to the SEC on 2023-03-21.
Scheduled sale ($1.1M) by EVP & Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $294.52 | 360 | $106K | 9.6% |
| 2 | $294.52 | 360 | $106K | 9.6% |
| 3 | $295.43 | 784 | $232K | 20.9% |
| 4 | $295.43 | 784 | $232K | 20.9% |
| 5 | $296.30 | 240 | $71K | 6.4% |
| 6 | $298.09 | 360 |
| $107K |
| 9.7% |
| 7 | $298.09 | 360 | $107K | 9.7% |
| 8 | $299.58 | 240 | $72K | 6.5% |
| 9 | $299.58 | 240 | $72K | 6.5% |
| 10 | $301.13 | 16 | $5K | 0.4% |
| Total | $296.38 avg | 3,744 | $1.1M | 100% |
| Filing → |
| VRTX | SELL | 2025-03-12 | $1.6M | — | Filing → |
| VRTX | SELL | 2024-11-13 | $1.6M | — | Filing → |
| VRTX | SELL | 2024-06-05 | $1.5M | — | Filing → |